NCT02397161

Brief Summary

Objective: To compare the effectiveness of EEG biofeedback mental attention-neuromuscular training (AT-NMT), neuromuscular training (NMT) alone, EEG biofeedback mental attention training (AT) alone, and no intervention for improving reactive balance performance among children with developmental coordination disorder (DCD). Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
172

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 24, 2015

Completed
1.3 years until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

December 15, 2015

Status Verified

December 1, 2015

Enrollment Period

1 year

First QC Date

March 9, 2015

Last Update Submit

December 13, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in motor control test composite latency score

    Baseline (0 month), post-intervention (3 months), and 3-month follow-up (6 months)

Secondary Outcomes (2)

  • Change in EEG mental attention level

    Baseline (0 month), post-intervention (3 months), and 3-month follow-up (6 months)

  • Change in surface EMG lower limb muscle onset latency

    Baseline (0 month), post-intervention (3 months), and 3-month follow-up (6 months)

Study Arms (4)

AT-NMT

EXPERIMENTAL

AT-NMT group - will receive a 12-week EEG biofeedback mental attention-neuromuscular training

Other: EEG biofeedback mental attention-neuromuscular training

NMT alone

EXPERIMENTAL

NMT group - will receive a 12-week neuromuscular training

Other: Neuromuscular training

AT alone

EXPERIMENTAL

AT group - will receive a 12-week EEG biofeedback mental attention training

Other: EEG biofeedback mental attention training

Control

NO INTERVENTION

Control group - no intervention for 12 weeks

Interventions

Mental attention training using EEG biofeedback and neuromuscular training using physio-therapeutic exercises

AT-NMT

Neuromuscular training using physio-therapeutic exercises

NMT alone

Mental attention training using EEG biofeedback

AT alone

Eligibility Criteria

Age6 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • to 9 years old;
  • a formal diagnosis of DCD based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) at a child assessment center;
  • a Bruininks-Oseretsky Test of Motor Proficiency giving a gross motor composite score of ≤42;
  • a Child Behavior Checklist attention problem subscale T score of ≥54.5, indicating an attention deficit;
  • attending a local mainstream school;
  • an intelligence level within the normal range; and
  • no experience in using the Brain Computer Interface system or similar apparatus.

You may not qualify if:

  • a diagnosis of neurological or other movement disorder;
  • any cognitive, psychiatric (comorbid ADHD will not be excluded), congenital, musculoskeletal or cardiopulmonary disorder that can affect motor performance;
  • receiving active therapies or treatments including complementary and alternative medicine;
  • demonstrating excessive disruptive behavior; or
  • those unable to follow instructions adequately.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hong Kong

Pokfulam, Hong Kong

Location

MeSH Terms

Conditions

Motor Skills Disorders

Condition Hierarchy (Ancestors)

Neurodevelopmental DisordersMental Disorders

Study Officials

  • Shirley SM Fong, PT, PhD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shirley SM Fong, PT, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, DRPC chairperson

Study Record Dates

First Submitted

March 9, 2015

First Posted

March 24, 2015

Study Start

July 1, 2016

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

December 15, 2015

Record last verified: 2015-12

Locations